Filing Details
- Accession Number:
- 0001209191-15-009372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-04 16:06:21
- Reporting Period:
- 2015-02-02
- Filing Date:
- 2015-02-04
- Accepted Time:
- 2015-02-04 16:06:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578696 | David Davidson | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-02 | 4,000 | $2.09 | 4,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-02 | 1,858 | $94.54 | 2,142 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-02 | 884 | $95.76 | 1,258 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-02 | 1,099 | $96.95 | 159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-02 | 159 | $98.40 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-02-02 | 4,000 | $0.00 | 4,000 | $2.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 59,239 | 2022-04-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2013.
- The range of prices for the transaction reported on this line was $94.00 to $95.00. The average weighted price was $94.5360. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $95.01 to $96.00. The average weighted price was $95.7632. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $96.60 to $97.45. The average weighted price was $96.9545. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $98.24 to $98.56. The average weighted price was $98.3985. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on February 13, 2013 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
